Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

300 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Discovery of clinical and demographic determinants of symptom burden in primary brain tumor patients using network analysis and unsupervised clustering.
Bergsneider BH, Vera E, Gal O, Christ A, King AL, Acquaye A, Choi A, Leeper HE, Mendoza T, Boris L, Burton E, Lollo N, Panzer M, Penas-Prado M, Pillai T, Polskin L, Wu J, Gilbert MR, Armstrong TS, Celiku O. Bergsneider BH, et al. Among authors: mendoza t. Neurooncol Adv. 2022 Dec 26;5(1):vdac188. doi: 10.1093/noajnl/vdac188. eCollection 2023 Jan-Dec. Neurooncol Adv. 2022. PMID: 36820236 Free PMC article.
Clinical utility of the MDASI-BT in patients with brain metastases.
Armstrong TS, Gning I, Mendoza TR, Weinberg JS, Gilbert MR, Tortorice ML, Cleeland CS. Armstrong TS, et al. J Pain Symptom Manage. 2009 Mar;37(3):331-40. doi: 10.1016/j.jpainsymman.2008.02.011. Epub 2008 Aug 3. J Pain Symptom Manage. 2009. PMID: 18676120 Free article.
Congruence of primary brain tumor patient and caregiver symptom report.
Armstrong TS, Wefel JS, Gning I, Acquaye A, Vera-Bolanos E, Gilbert MR, Cleeland CS, Mendoza T. Armstrong TS, et al. Among authors: mendoza t. Cancer. 2012 Oct 15;118(20):5026-37. doi: 10.1002/cncr.27483. Epub 2012 Mar 13. Cancer. 2012. PMID: 22415423 Free article.
Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma.
Armstrong TS, Wefel JS, Wang M, Gilbert MR, Won M, Bottomley A, Mendoza TR, Coens C, Werner-Wasik M, Brachman DG, Choucair AK, Mehta M. Armstrong TS, et al. J Clin Oncol. 2013 Nov 10;31(32):4076-84. doi: 10.1200/JCO.2013.49.6067. Epub 2013 Oct 7. J Clin Oncol. 2013. PMID: 24101048 Free PMC article. Clinical Trial.
300 results